OpGen Inc
OpGen, Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company's products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It also provides laboratory services; collaboration services, includ… Read more
OpGen Inc (OPGN) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.033x
Based on the latest financial reports, OpGen Inc (OPGN) has a cash flow conversion efficiency ratio of -0.033x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-333.35K) by net assets ($10.16 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
OpGen Inc - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how OpGen Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
OpGen Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of OpGen Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mitrabara Adiperdana PT
JK:MBAP
|
-0.004x |
|
CHINA NEW ENERGY LS-00025
F:9H5
|
N/A |
|
SoftOx Solutions AS
OL:SOFTX
|
0.003x |
|
Lokum Deweloper SA
WAR:LKD
|
-0.043x |
|
United Express Inc
PINK:UNXP
|
-0.001x |
|
Specialty Natural Products PCL
BK:SNPS
|
N/A |
|
KERRY EXPRESS (THAILAND)
BK:KEX-R
|
N/A |
|
Allcargo Terminals Ltd
NSE:ATL
|
0.638x |
Annual Cash Flow Conversion Efficiency for OpGen Inc (2012–2025)
The table below shows the annual cash flow conversion efficiency of OpGen Inc from 2012 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $7.38 Million | $-4.87 Million | -0.660x | 0.00% |
| 2024-12-31 | $7.38 Million | $-4.87 Million | -0.660x | -153.27% |
| 2023-12-31 | $-11.56 Million | $-14.32 Million | 1.239x | +145.88% |
| 2022-12-31 | $7.58 Million | $-20.45 Million | -2.699x | -417.97% |
| 2021-12-31 | $41.22 Million | $-21.48 Million | -0.521x | +52.80% |
| 2020-12-31 | $21.19 Million | $-23.40 Million | -1.104x | +58.80% |
| 2019-12-31 | $4.29 Million | $-11.51 Million | -2.680x | +19.93% |
| 2018-12-31 | $3.31 Million | $-11.07 Million | -3.347x | +67.22% |
| 2017-12-31 | $1.40 Million | $-14.30 Million | -10.210x | -87.47% |
| 2016-12-31 | $3.17 Million | $-17.25 Million | -5.446x | -185.74% |
| 2015-12-31 | $7.49 Million | $-14.28 Million | -1.906x | -385.45% |
| 2014-12-31 | $-8.07 Million | $-5.39 Million | 0.668x | -83.67% |
| 2013-12-31 | $-1.83 Million | $-7.49 Million | 4.088x | +518.66% |
| 2012-12-31 | $8.15 Million | $-7.96 Million | -0.977x | -- |